Ajanta Pharma receives USFDA approval for Almotriptan Malate tablet

Ajanta Pharma has received final USFDA approval for its generic version of acute migraine pain relief drug almotriptan malate tablets . The company will produce the table in multiple strengths of 6.25mg and 12.5mg. The product almotriptan is a generic version of Janssen Pharmaceuticals’ Axert tablets which is used for pain relief.

Company Profile : Ajanta Pharma Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*